RT Journal Article
SR Electronic
T1 Cardiovascular Screening and Lipid Management in Breast Cancer Survivors
JF The Journal of the American Board of Family
                Medicine
JO J Am Board Fam Med
FD American Board of Family Medicine
SP 894
OP 902
DO 10.3122/jabfm.2020.06.190459
VO 33
IS 6
A1 S. Tucker Price
A1 Lisa D. Mims
A1 Marty S. Player
A1 Carole Berini
A1 Suzanne Perkins
A1 Chanita Hughes Halbert
A1 Vanessa A. Diaz
YR 2020
UL http://www.jabfm.org/content/33/6/894.abstract
AB Background: Cardiovascular disease (CVD) is the leading cause of death among breast cancer (BC) survivors. BC survivors are at increased risk of CVD due to a higher prevalence of risk factors. Current data are limited on the cardiovascular screening practices and lipid management in this population in primary care settings.Methods: A retrospective case control study was performed with 105 BC survivors and 210 matched controls (based on age and medical comorbidities of diabetes, hypertension, and hyperlipidemia). BC survivors were established with primary care practices within a large academic institution and had completed primary cancer treatment. Data on screening for CVD and lipid management were collected via a retrospective chart review.Results: The average BC survivor was 63 years old, with 9 years since diagnosis. Compared with matched controls, BC survivors had more cholesterol screening (88% vs 70%, P &lt; .001) and active statin prescriptions (63% vs 40%, P &lt; .05) if indicated by the Atherosclerotic Cardiovascular Disease Calculator. There were no differences in CVD screening in White and African American BC survivors. However, African American BC survivors were more likely to have hypertension (P &lt; .01) and have a body mass index in the overweight and obese category (P &lt; .001) than White BC survivors. Older BC survivors were more likely to receive cholesterol screening.Discussion: This study demonstrates that BC survivors who have an established primary care provider have improved cholesterol screening and statin therapy based on their risk of developing chronic diseases.